date,title,source
Oct-24-18,"miRagen Therapeutics to Report Third Quarter 2018 Financial Results and Host Conference Call on November 7, 2018",GlobeNewswire
Oct-29-18,miRagen Therapeutics to Present at two Investor Conferences in November 2018,GlobeNewswire
Nov-01-18,Miragen Therapeutics to Present New Cobomarsen Phase 1 Clinical Trial Data at the 2018 American Society of Hematology Annual Meeting,GlobeNewswire
Nov-07-18,"Signal Genetics, Inc. (MGEN) Reports Q3 Loss, Misses Revenue Estimates",Zacks
Nov-07-18,miRagen Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update,GlobeNewswire
Dec-18-18,"Hedge Funds Are Crazy About Miragen Therapeutics, Inc. (MGEN)",Insider Monkey
Dec-20-18,miRagen Therapeutics to Present New Cobomarsen Clinical Trial Data for Adult T-Cell Leukemia/Lymphoma and Cutaneous T-Cell Lymphoma at the 11th Annual T-Cell Lymphoma Forum,GlobeNewswire
Jan-10-19,miRagen Announces New Clinical Data in Patients With Three Different Types of Blood Cancers Treated With Cobomarsen,GlobeNewswire
Jan-24-19,"Colorado biotech firms are developing drugs to fight cancer, help children and cut down on excessive sweating",American City Business Journals
Feb-20-19,miRagen Therapeutics to Report Fourth Quarter and Fiscal 2018 Financial Results and Host a Conference Call on March 13th,GlobeNewswire
Mar-06-19,miRagen Therapeutics to Present a Corporate Overview at the 29th Annual Oppenheimer & Co. Healthcare Conference,GlobeNewswire
Mar-13-19,"Signal Genetics, Inc. (MGEN) Reports Q4 Loss, Misses Revenue Estimates",Zacks
Mar-13-19,miRagen Announces Fourth Quarter and Full Year 2018 Financial Results and Provides 2019 Outlook,GlobeNewswire
Apr-25-19,miRagen Therapeutics to Report First Quarter 2019 Financial Results and Host a Conference Call on May 8th,GlobeNewswire
Apr-26-19,"miRagen Announces New Clinical Data for Cobomarsen in ATLL Patients at the 19th Annual HTLV Congress in Lima, Peru",GlobeNewswire
Apr-29-19,miRagen Therapeutics Announces New Data Supporting the Potential Use of Remlarsen to Prevent Corneal Fibrosis at the 2019 ARVO Meeting,GlobeNewswire
May-01-19,"Earnings Preview: Signal Genetics, Inc. (MGEN) Q1 Earnings Expected to Decline",Zacks
May-08-19,"Signal Genetics, Inc. (MGEN) Reports Q1 Loss, Misses Revenue Estimates",Zacks
May-08-19,miRagen Announces First Quarter 2019 Financial Results and Provides Corporate Update,GlobeNewswire
May-21-19,miRagen Presents Preclinical Data in Pulmonary Fibrosis Using Second Generation microRNA-29 Replacement Product Candidate at the 2019 American Thoracic Society International Conference,GlobeNewswire
May-28-19,miRagen Therapeutics to Present a Corporate Overview at the Jefferies 2019 Global Healthcare Conference,GlobeNewswire
Jun-21-19,Some Miragen Therapeutics (NASDAQ:MGEN) Shareholders Have Copped A Big 66% Share Price Drop,Simply Wall St.
